本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

40.89
-0.0600-0.15%
盘后40.890.00000.00%18:17 EDT
成交量:71.65万
成交额:2,947.34万
市值:17.18亿
市盈率:-15.04
高:41.95
开:40.49
低:40.39
收:40.95
数据加载中...
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

重要事件披露

Form 8-K - Current report
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities